Skip to main content
TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.100
+0.030 (1.45%)
Apr 28, 2026, 4:00 PM EDT - Market closed

TherapeuticsMD Revenue

In the year 2025, TherapeuticsMD had annual revenue of $3.02M with 71.61% growth. TherapeuticsMD had revenue of $893.00K in the quarter ending December 31, 2025, with 33.88% growth.

Revenue (ttm)
$3.02M
Revenue Growth
+71.61%
P/S Ratio
8.10
Revenue / Employee
$3,022,000
Employees
1
Market Cap
24.31M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.02M1.26M71.61%
Dec 31, 20241.76M459.00K35.25%
Dec 31, 20231.30M-68.66M-98.14%
Dec 31, 202269.96M67.39M2,619.12%
Dec 31, 20212.57M-62.30M-96.03%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
InterCure 72.16M
Rockwell Medical 69.26M
Aytu BioPharma 62.64M
Biofrontera 41.71M
Zhengye Biotechnology Holding 21.46M
China Pharma Holdings 4.14M
BioXcel Therapeutics 642.00K
Talphera 28.00K
Revenue Rankings

TXMD News

More News